Protein tyrosine phosphatase 1B negatively regulates S100A9 mediated apoptosis during respiratory syncytial virus infection

Robert Foronjy (Scarsdale, United States of America), Pius Ochieng, Edward Eden, Matthias Salathe, Abdoulaye Dabo, Nathalie Schmid, Michael Campos, Neville Cummins, Robert Foronjy, Patrick Geraghty

Source: International Congress 2015 – Advances from translational research in respiratory infections
Session: Advances from translational research in respiratory infections
Session type: Poster Discussion
Number: 5038
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Robert Foronjy (Scarsdale, United States of America), Pius Ochieng, Edward Eden, Matthias Salathe, Abdoulaye Dabo, Nathalie Schmid, Michael Campos, Neville Cummins, Robert Foronjy, Patrick Geraghty. Protein tyrosine phosphatase 1B negatively regulates S100A9 mediated apoptosis during respiratory syncytial virus infection. Eur Respir J 2015; 46: Suppl. 59, 5038

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cytokine production of leukocytes in response to respiratory syncytial virus is suppressed by cigarette smoking and in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016

Lymphocytes mediate the anti-apoptotic effect of respiratory syncytial virus on human neutrophils
Source: Annual Congress 2007 - Bronchiolitis - genetics and immunity
Year: 2007


Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma
Source: Eur Respir J 2002; 19: 68-75
Year: 2002



Ubiquitination of DDX21 in airway epithelial cells infected with respiratory syncytial virus
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015


The role of viruses in chronic bronchitis and exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 68-75
Year: 2013


Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice
Source: Eur Respir J 2004; 24: 143-149
Year: 2004



Viruses in asthma and COPD: mechanisms and defence
Source: Annual Congress 2005 - Microorganisms: good, bad or ugly in allergic respiratory disease
Year: 2005

The role of neutrophils in viral clearance during respiratory syncytial virus (RSV) disease
Source: Annual Congress 2013 –Pulmonary infection in children: diagnosis and long-term effects
Year: 2013



IP-10 is selectively produced in the airways upon respiratory virus infection
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013


Glycosylation studies of G-protein of BA genotype of group B human respiratory syncytial virus in mammalian cells
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015

Inflammatory epithelial cytokines after in vitro respiratory syncytial viral infection are associated with reduced lung function
Source: ERJ Open Res, 7 (3) 00365-2021; 10.1183/23120541.00365-2021
Year: 2021



Respiratory syncytial virus induces glucocorticoid insensitivity
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015


Effects of respiratory syncytial virus and adenovirus infection in cytokine expression and nuclear factor-κB activation human bronchial epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 192s
Year: 2006

RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells
Source: Eur Respir J 2012; 39: 712-720
Year: 2012



LATE-BREAKING ABSTRACT: RV568, a narrow spectrum kinase inhibitor (NSKI), inhibits virus induced nasal interleukin-8 (IL8) in the human viral challenge model where healthy adult male volunteers were experimentally inoculated with live respiratory syncytial virus
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013

TNF-mediated alveolar macrophage necroptosis drives disease pathogenesis during respiratory syncytial virus infection
Source: Eur Respir J, 57 (6) 2003764; 10.1183/13993003.03764-2020
Year: 2021



LATE-BREAKING ABSTRACT: Effects of a single treatment with PC786, a novel inhibitor of respiratory syncytial virus replication, on viral load and biomarkers in fully differentiated human bronchial epithelial cells
Source: International Congress 2016 – Translational research in respiratory infections
Year: 2016


Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model
Source: Eur Respir J 2011; 38: 401-408
Year: 2011



LSC 2013 abstract - Mast cells support rhinovirus but not respiratory syncytial virus replication and contribute to the pro-inflammatory response to rhinovirus
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013

Human neutrophil elastase (HNE) in acute bronchiolitis
Source: Annual Congress 2006 - Bronchiolitis in infancy, treatment and outcome
Year: 2006